Bevacizumab-IRDye800 Is an Effective Alternative to Anti-Carcinoembryonic Antigen (CEA) for Labeling Low CEA-Expressing Colorectal Tumors.

Subjects

Subjects :

*COLON cancer
*BEVACIZUMAB
*CARCINOEMBRYONIC antigen
*TUMORS
*ALTERNATIVE medicine

Details

Language :

English

ISSN :

10727515

Volume :

225

Database :

Academic Search Index

Journal :

Journal of the American College of Surgeons

Publication Type :

Academic Journal

Accession number :

125173796

Full Text :

https://doi.org/10.1016/j.jamcollsurg.2017.07.067